Asia
Thyrocare Technologies Board to Consider Third Interim Dividend for Fiscal 2025
Diagnostics firm Thyrocare Technologies (NSE:THYROCARE, BOM:539871) said its board of directors will meet on May 7 to consider the declaration of final dividend for financial year 2025-26, ended March 31, according to a filing with the Indian bourses on Wednesday.
BOM:539871NSE:THYROCARE